In a phase 2 trial, about half of cancer patients reported sustained reductions in depression and anxiety 2 years after a ...

Electroconvulsive therapy (ECT) lowered the risk of death by suicide 34% among patients with severe depression, according to ...

A single dose of psilocybin provided sustained reductions in depression and anxiety among cancer patients diagnosed with ...

The psilocybin found in "magic mushrooms" might be key to quelling depression among people battling cancer, a new study found ...

A biotech company founded in Wales last year has raised $140mn in its first financing round to develop drugs for severe ...

New results from a clinical trial reveal that a single dose of psilocybin—a naturally occurring psychedelic compound found in ...

When we think of the symptoms of major depressive disorder (MDD) we typically think of persistent feelings of sadness, lack ...

New research shows psilocybin can produce lasting reductions in depression and anxiety in cancer patients with major ...

New results from a clinical trial published by Wiley online in CANCER reveal that a single dose of psilocybin can provide sustained reductions in depression and anxiety in individuals with cancer ...

Draig Therapeutics has been awarded £107m to advance the development of novel therapies for major neuropsychiatric disorders ...